52例克林霉素治疗急性下呼吸道感染的疗效观察

Clinical observation of 52 cases of clindamycin treatment of acute lower respiratory tract infection

目的:观察克林霉素对治疗急性下呼吸道感染的有效性。方法:选取我院2010年至2011年接收的急性下呼吸道感染患者52例为观察对象。患者经检查确诊为急性下呼吸道感染后,接受克林霉素静脉滴注,观察用药的有效率和不良反应发生率。结果:30例痊愈,16例显效,总有效率为88.46%,细菌清除率为90.48%,不良反应发生率为5.77%。结论:克林霉素对急性下呼吸道感染的治疗效果较为显著,且不良反应少,是一种相对安全的治疗药物。

Objective: To observe the effectiveness of clindamycin in the treatment of acute lower respiratory infections. Methods: I received in hospital from 2010 to 2011 of acute lower respiratory infection (52 patients) for the observation object. Patients diagnosed as acute lower respiratory infections, accept the intravenous infusion of clindamycin, observation of medication efficiency and incidence of adverse reactions. Results: 52 cases of upper respiratory tract infection after the clindamycin infusion course of treatment, 30 cases recovered, 16 cases markedly effective, 88.46% of the total effective rate of bacterial clearance rate was 90.48 percent, of adverse reactions was 5.77%. Conclusion: Clindamycin treatment of acute lower respiratory infections, more significantly, and fewer adverse reactions, not to damage the liver and kidney function, is a relatively safe therapy.